Milk of magnesia (MOM) is a common antacid used to treat various gastrointestinal issues, including heartburn and acid reflux. It has been used as a medicine since the 1800s, but it is only in recent years that its use has become more widespread among medical professionals. As with any medication, it is important to understand the proper dosage of Milk of Magnesia for your patients before administering it. In this article, we will discuss everything you need to know about Milk of Magnesia dosage for medical professionals. From information on generic and brand-name products to how to properly prescribe MOM, read on for a comprehensive guide to ensuring the safety and effectiveness of this useful remedy.
The most common side effect of Milk of Magnesia is diarrhea. This usually goes away after a few days. Other side effects may include:
-abdominal pain
-bloating
-gas
-nausea
-vomiting
Milk of Magnesia is a medication that should be taken with caution. There are certain times when it is not recommended to take the medication. These include:
-When you are pregnant or breastfeeding
-When you have kidney disease
-When you are taking other medications that could interact with Milk of Magnesia
-When you have a history of gastrointestinal problems
It takes about 30 minutes for Milk of Magnesia to work. However, the full effects may not be felt for 1-2 hours.
Milk of magnesia is a safe and effective treatment for symptoms of constipation when taken in the correct dosage. It can be used by both adults and children.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Lesser-known lobular breast cancer on the rise in U.S. women
2.
Study finds that AI is better at forecasting the risk of developing cancer.
3.
Kate Middleton and Remission: Oncologists Weigh In
4.
According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.
5.
What Role Should Genomic Classifier Testing Play in Prostate Cancer?
1.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
2.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
3.
Tumor-Specific Fluorescent Peptide Navigation in Surgical Oncology
4.
Digital Blood Cell Morphology Libraries for Longitudinal Hematologic Monitoring
5.
The importance of understanding normal serum osmolality
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
5.
Best Practices in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation